
Exploring the role of Elafibranor in Primary Biliary Cholangitis (PBC) treatment, this podcast delves into the significant findings of the ELATIVE trial, highlighting its potential as an effective and safe second-line treatment option for patients who have had inadequate responses or side effects with Ursodeoxycholic acid. Original article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US